CN103355334A - Sterilization composition containing pyraclostrobin and famoxadone - Google Patents
Sterilization composition containing pyraclostrobin and famoxadone Download PDFInfo
- Publication number
- CN103355334A CN103355334A CN2013103268328A CN201310326832A CN103355334A CN 103355334 A CN103355334 A CN 103355334A CN 2013103268328 A CN2013103268328 A CN 2013103268328A CN 201310326832 A CN201310326832 A CN 201310326832A CN 103355334 A CN103355334 A CN 103355334A
- Authority
- CN
- China
- Prior art keywords
- famoxadone
- pyraclostrobin
- bactericidal composition
- sterilization composition
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention relates to a sterilization composition containing pyraclostrobin and famoxadone. The sterilization composition is prepared by compounding effective ingredients of pyraclostrobin and famoxadone in binary, wherein the mass ratio of pyraclostrobin to famoxadone is 1-50 : 50-1. In the preparation, the mass of the effective ingredients of pyraclostrobin and famoxadone accounts for 1%-80% that of the composition; and the residual parts are auxiliary components that are permissible and acceptable in pesticides. The preparations of the sterilization composition can be missible oil, suspension preparation, wettable powder, water dispersible granules, water emulsion, microemulsion, granules and microcapsules. The sterilization composition is mainly used for preventing and treating important diseases such as powdery mildew, rust diseases, glume blight, net blotch, downy mildew, late blight and the like in ascomycetes, bassidiomycetes and oomycetes subclass.
Description
Technical field
The present invention relates to the agriculture chemical compounding technical field, particularly relate to and a kind ofly contain pyraclostrobin Yu the bactericidal composition of famoxadone.
Background technology
Pyraclostrobin (pyraclostrobin) is the bactericide of BASF AG's latest model methoxy acrylic.Pyraclostrobin is the New-type wide-spectrum bactericide.The mechanism of action: be the mitochondrial respiratory inhibitor. by stoping electronics to shift in cytochrome b cl is synthetic.There is protection, treatment, blade infiltration conduction.Pyraclostrobin missible oil shows that through the field control effectiveness test result powdery mildew of cucumber, downy mildew and banana freckle, leaf spot are had to control efficiency preferably.Chemical name: N-f2 mono-" 1 one (4 monochloro-benzene) 1H-pyrazoles-3-yloxymethyl " benzene is foretold N mono-methoxy methyl carbamate.Its chemical structural formula is
Famoxadone is new and effective, broad spectrum pesticide. suitable crop is as wheat, barley, pea, beet, rape, grape, potato, pawl class, capsicum, tomato etc.Be mainly used in preventing and treating important disease in Ascomycetes, Basidiomycetes, oomycetes subclass as powdery mildew, rust, glume blight, net blotch, downy mildew, late blight etc.There is lipophilicity, after spraying on crop leaf, easily adhere to, not by the rain drop erosion special efficacy.The chemistry of famoxadone is called 3-anilino--5-methyl-5-(4-Phenoxyphenyl)-1,3-azoles quinoline-2, and the 4-diketone, its chemical structural formula is
.
Using chemical agent is the most effectively means of controlling plant diseases.But long-term use single chemical bactericide continuously high dose, easily cause the problems such as residual, the environmental pollution of medicament and anti-pesticide resistance fungi development.Reasonably chemical bactericide is composite or be mixed and have the expansion fungicidal spectrum, improve control efficiency, extend the optimum period for applying fertilizer, reduce dosage, reduce poisoning, reduce residual, delay Antifungal resistance and the positive characteristics such as drug-fast generation and development, bactericide compounded is one of the effective method the most addressed the above problem.Exploitation new product bactericide price is constantly soaring, and by contrast, exploitation is efficient with research, low toxicity, low-residual composite be mixed there is small investment, the lead time is short and be subject to domestic and international attention, the numerous and confused dynamics that develops that strengthens.We filter out pyraclostrobin Yu famoxadone carries out compositely on the basis of lab screening and field trial, have obvious synergistic effect.And about pyraclostrobin Yu the composite bactericidal composition of famoxadone and application there is no at present the people and reported.
Summary of the invention
Based on above situation, the object of the invention is to provide a kind of new and effective pesticide sterilizing composite.Be mainly used in preventing and treating important disease in Ascomycetes, Basidiomycetes, oomycetes subclass as powdery mildew, rust, glume blight, net blotch, downy mildew, late blight etc.
Technical scheme of the present invention realizes by following measures:
A kind ofly contain pyraclostrobin Yu the bactericidal composition of famoxadone, the active ingredient pyraclostrobin of this bactericidal composition is Yu two yuan of famoxadones are composite, and all the other are auxiliary element.Active ingredient pyraclostrobin in wherein said bactericidal composition is Yu the mass ratio of famoxadone is 1～50: 50～1, described bactericidal composition of the present invention is through the toxicity test experimental verification, pyraclostrobin is Yu the mass ratio of famoxadone is 1～20: 20～1 o'clock, and synergistic effect is better.
The formulations of pesticide that described bactericidal composition of the present invention can be prepared are missible oil, suspending agent, wetting powder, water dispersible granules, aqueous emulsion, microemulsion, granule, microcapsule formulations.Wherein the active ingredient pyraclostrobin is Yu the gross mass of famoxadone in preparation accounts for 1%～80% of the whole quality of the pharmaceutical preparations, while wherein accounting for 5%～60%, and toxicity and the residual balance preferably that reaches, cost is also lower.
The specific embodiments of the formulations of pesticide that bactericidal composition of the present invention is mixed with is as follows:
Described bactericidal composition is cream preparation, and the mass fraction of component is: 1～50 part of pyraclostrobin; 1～50 part of famoxadone; 10～30 parts of conventional emulsifiers; 20～50 parts of conventional solvents; 1～5 part of conventional synergist.The concrete production stage of this cream preparation adds emulsifier, the synergist rear oily liquids that becomes transparent and homogeneous that stirs again for first active ingredient pyraclostrobin Yu famoxadone being added in solvent after dissolving fully, filling, can be made into the cream preparation of the present composition.
Described bactericidal composition is suspending agent, and the mass fraction of component is: 1～50 part of pyraclostrobin; 1～50 part of famoxadone; 5～20 parts of dispersants; 1～5 part of antifreezing agent; 0.1～2 part of thickener; 0.1～0.8 part of defoamer; 0～10 part of penetrating agent; 0.1～5 part of pH value conditioning agent; Water, surplus.The concrete production stage of this suspending agent is for first mixing other auxiliary agents, mix through high speed shear, add the active ingredient pyraclostrobin Yu famoxadone, in ball crusher, abrading-ball is 2～3 hours, make a diameter all below 5mm, can be made into the suspending agent preparation of the present composition.
Described bactericidal composition is wetting powder, and the mass fraction of component is: 1～50 part of pyraclostrobin; 1～50 part of famoxadone; 3～10 parts of dispersants; 1～5 part of wetting agent; Filler, surplus.The concrete production stage of this wetting powder is: by above-mentioned formula, the active ingredient pyraclostrobin is mixed Yu famoxadone and dispersant, wetting agent and filler, uniform stirring in stirred tank, mixing after airslide disintegrating mill, can be made into the wetting powder of the present composition.
Described bactericidal composition is water dispersible granules, and the mass fraction of component is: 1～50 part of pyraclostrobin; 1～50 part of famoxadone; 3～10 parts of dispersants; 1～10 part of wetting agent; 1～5 part of disintegrant; Filler, surplus.The concrete production stage of this water dispersible granules is: by above-mentioned formula, the active ingredient pyraclostrobin is mixed Yu famoxadone and dispersant, wetting agent, disintegrant and filler, with micro jet, pulverize, through mediating, then add in the fluidized bed prilling dryer and carry out granulation, drying, screening by sample analysis, can be made into the water dispersible granules of the present composition.
Described bactericidal composition is aqueous emulsion, and the mass fraction of component is: 1～50 part of pyraclostrobin; 1～50 part of famoxadone; 3～30 parts of emulsifier; 5～15 parts of solvents; 2～15 parts of stabilizing agents; 1～5 part of antifreezing agent; 0.1～8 part of defoamer; 0.2～2 part of thickener; Water, surplus.The concrete production stage of this aqueous emulsion is: at first by pyraclostrobin Yu famoxadone, solvent and emulsifier, cosolvent are added together, make to be dissolved into uniform oil phase; By part water, antifreeze, other the insecticides adjuvant such as antimicrobial mixes into uniform water; When the reactor high speed stirs, oil phase is added to water, slowly add water until reach the phase inversion point, open clipper and carry out high speed shear, and add remaining water, shear about half an hour, form the aqueous emulsion of oil-in-water type, can be made into the aqueous emulsion of the present composition.
Described bactericidal composition is microemulsion, and the mass fraction of component is: 1～50 part of pyraclostrobin; 1～50 part of famoxadone; 10～30 parts of emulsifier, 1～8 part of antifreezing agent, 0.5～10 part of stabilizing agent, 20～50 parts of conventional solvent cosolvents.Pyraclostrobin, Yu famoxadone dissolves fully with cosolvent, then is added to other compositions such as emulsifier, antifreezing agent stabilizing agent, evenly mix, finally add water, after fully stirring, can be made into microemulsion.
Described bactericidal composition is granule, and the mass fraction of component is: 1～50 part of pyraclostrobin; 1～50 part of famoxadone; 1～10 part of wetting dispersing agent; 0.1～5 part of thickener; 0.1～5 part of defoamer; Castor oil, surplus is supplied.The active ingredient pyraclostrobin is mixed in the ratio of formula Yu each components such as famoxadone, dispersant, stabilizing agent, defoamer and solvents, after putting into the grinding of sand milling still, send in mixer for well-distribution and mix and get product.
Described bactericidal composition is microcapsule formulations, and the mass fraction of component is: 1～50 part of pyraclostrobin; 1～50 part of famoxadone; 5～20 parts, urea; 5～20 parts, formaldehyde; 5～20 parts of emulsifying dispersants; 1～5 part of antifreezing agent; 0.1～2 part of thickener; 0.1～0.8 part of defoamer; Water, surplus.In being housed, the there-necked flask of agitating device adds urea and formaldehyde (the amount of substance ratio is about l:1.5～2.0), with the pH value to 8 of sodium hydroxide solution regulator solution～9 left and right, then be warming up to 70～80 ℃, reaction obtains stable urea resin prepolymer.Get a certain amount of pyraclostrobin Yu famoxadone is dissolved in cyclohexane, and add emulsifying dispersant in solution, follow vigorous stirring, the O/W type stable emulsion that to be made into the aqueous solution of take containing emulsifying dispersant be water.Above-mentioned urea resin prepolymer is added in emulsion, regulate the pH value, polymerization reaction take place under the acid catalysis condition, be wrapped oil phase substance, forms microcapsule granule.Slowly heat up, solidify, temperature is controlled at 40～50 ℃, hardening time 1h.Selection adds appropriate auxiliary agent, the microcapsule suspending agent that gets final product stablely.
Wherein above-described emulsifier is selected from calcium dodecyl benzene sulfonate and aliphatic acid polyethenoxy ether, the alkylphenol polyoxyethylene sulfosuccinate, styrylphenol polyoxyethylene ether, polyoxyethylene nonylphenol ether, castor oil polyoxyethylene ether, aliphatic acid polyethenoxy base ester, any or more than one any mixtures than forming in polyoxyethylene aliphatic alcohol ether.
Described solvent is dimethylbenzene or biodiesel, toluene, diesel oil, methyl alcohol, ethanol, n-butanol, isopropyl alcohol, the turpentine-based vegetable oil code name is ND-45, solvent naphtha, dimethyl formamide, dimethyl sulfoxide (DMSO), one or more in the water equal solvent are arbitrarily than the mixture formed.
It is LG-3, GY-D1252, GY-D1256, SNWGF-01 that described dispersant is selected from the polycarboxylate code name, the lignosulfonates code name is 201107,21108, alkylphenol polyoxyethylene methyl ether condensate sulfate, the alkylsulfonate calcium salt, the naphthalene sulfonic acid-formaldehyde condensation product sodium salt, alkylphenol polyoxyethylene, polyoxyethylene carboxylate, aliphatic amine polyoxyethylene ether, one or more in the fatty acid glyceride APEO.
Described wetting agent is selected from lauryl sodium sulfate, calcium dodecyl benzene sulfonate, and Nekal BX, moistening bleeding agent F, alkylbenzenesulfonate polyoxyethylene triphen is phosphenylic acid salt dimly, spaonin powder, silkworm excrement, one or more in the soapberry powder.
Described disintegrant is selected from bentonite, urea, ammonium sulfate, aluminium chloride, citric acid, succinic acid, one or more in sodium bicarbonate.
Described thickener is selected from xanthans, carboxymethyl cellulose, carboxyethyl cellulose, methylcellulose, Magnesiumaluminumsilicate, in polyvinyl alcohol one or more.
Described stabilizing agent is selected from sodium citrate, a kind of in resorcinol.
Described antifreezing agent is selected from ethylene glycol, propane diols, one or more in glycerine.
Described defoamer is selected from silicone oil, silicone compound, C
10-20the saturated fat acid compounds, C
8-10one or more of fatty alcohol.
Described filler is selected from kaolin, diatomite, bentonite, attapulgite, white carbon, starch, one or more in precipitated calcium carbonate.
The present invention be take pyraclostrobin Yu the composite bactericide that famoxadone is active ingredient has obvious synergistic effect, delays the drug-fast generation in key, and has reduced to become to produce cost and use cost, can be used for the improvement of resistance disease.Be mainly used in preventing and treating important disease in Ascomycetes, Basidiomycetes, oomycetes subclass as powdery mildew, rust, glume blight, net blotch, downy mildew, late blight etc.
Embodiment
For making technical scheme of the present invention, purpose and advantage are clearer, and the present invention describes with following specific embodiment, but the present invention is not limited to these examples.The mode that effect experiment of the present invention adopts indoor biometrics and field trial to combine, if no special instructions, the ratio of below mentioning is all ratio of quality and the number of copies.
Embodiment: pyraclostrobin proportioning co-toxicity experiments different from famoxadone.
1.1 reagent agent
The former medicine of 95% pyraclostrobin, the former medicine of 95% famoxadone, above-mentioned former medicine provides by research and development department of extra large rel medicine company limited company.
1.2 test target
Never executed pyraclostrobin Yu famoxadone from Shouguang, Shandong and cucumber of the same type gathers and separates potted plantly, for the examination cucumber variety: Chang Chun Mi Ci.
1.3 test method
1.3.1 medicament preparation
First use the former medicine of acetone solution, according to the result of preliminary experiment, two appropriate former medicines are made into to several different proportionings, then it is stand-by with acetone, each processing to be diluted to respectively to several concentration gradients.
Susceptible cucumber variety Chang Chun Mi Ci cultivation, in pot for growing seedlings, is placed in to greenhouse and cultivates, and plant grows to three to four leaf after dates, gathers the blade of identical leaf age, for cultivation and the mensuration of cucumber downy mildew germ.
1.3.2 the cultivation of bacterium of downy mildew of cucumber and the preparation of spore suspension
Bacterium of downy mildew of cucumber adopts the plants method to cultivate under 20 ℃, the condition of 12h alternation of light and darkness, and every 30 d turn culture 1 time.During inoculation, with the conidium on sterile water wash-out incidence of leaf, being mixed with spore concentration is l * 10
6the suspension of individual/mL.
1.3.3 strains tested sensitivity testing
Adopt leaf dish moisturizing method to carry out toxicity test.First the blade of collection is prepared into to the leaf dish that diameter is 1.5cm, mix at random, be placed in respectively the series concentration liquid configured and soak lh, 50 leaf dishes of each concentration, test is with the blank that is treated to of adding medicine not, after soaking end, leaf faces up and puts on the blotting paper wetting in identical liquor strength, liquid on the leaf dish is blotted, the spore suspension l0L prepared is inoculated in to leaf dish central authorities, after room temperature is placed 5 min, is placed under 20 ℃, the condition of 1 2h alternation of light and darkness and cultivates, measure the onset area on the leaf dish after 10d, calculate EC
50.
On the basis of preliminary experiment, respectively single dose pyraclostrobin and famoxadone are carried out to toxicity test in order to upper method, the two EC
50value is respectively 12.0836 ㎎/l and 8.8941 ㎎/l.
The percentage that accounts for the leaf disc area according to lesion area is divided sick level
0 grade: anosis;
1 grade: the sorus area accounts for below 5% of whole leaf area;
3 grades: the sorus area accounts for below the 6%-10% of whole leaf area;
5 grades: the sorus area accounts for below the 11%-20% of whole leaf area;
7 grades: the sorus area accounts for below the 21%-50% of whole leaf area;
9 grades: the sorus area accounts for more than 50% of whole leaf area;
1.3.4 mixture toxicity test and interpretation of result
Carry out the toxicity test of mixture according to mixed ratio by single dose toxicity test method.
If contrast lethality<5%, do not proofread and correct, the contrast lethality, between 5%-20%, is proofreaied and correct by formula 2, the contrast lethality > 20%, test need be reformed.
The logarithm value of drug concentration (mg/L) of take is independent variable x, and the probability value of corrected mortality of take is dependent variable y, sets up respectively the virulence regression equation formula, adopts DPS software to calculate the EC of single dose and each proportioning mixture
50calculate co-toxicity coefficient (CTC) according to the abundant method of Sun Yun.Co-toxicity coefficient CTC, computing formula is as follows: (take pyraclostrobin as the standard medicament, its toxicity index is 100):
The EC of the toxicity index of famoxadone (TI)=pyraclostrobin
50the EC of/famoxadone
50* 100
The EC of the true toxicity index (ATI) of M=pyraclostrobin
50the EC of/M
50* 100
The TI of the TI of the theoretical toxicity index (TTI) of M=pyraclostrobin * P pyraclostrobin+famoxadones * P famoxadone
The TTI of the ATI/M of the co-toxicity coefficient of M (CTC)=M * 100
In formula:
M is pyraclostrobin from the mixture of the different proportionings of famoxadone
The P pyraclostrobin is pyraclostrobin shared ratio in mixture
P famoxadone Wei famoxadone shared ratio in mixture.
2.1 toxicity test result
Table 1 pyraclostrobin Yu famoxadone to the toxicity test of cucumber downy mildew
As can be seen from the table, the result of the test of different proportion proportioning shows, dilute respectively and all show stronger synergistic effect in the active ingredient ratio, wherein take pyraclostrobin: famoxadone as 1:50～50:1 the time synergistic effect good, suggestion is carried out further field control effectiveness test to suitable proportion 1:20～20:1 left and right mixture preparation, to estimate its field practical application effect.
3, field trial control tomato late blight, downy mildew of garpe
3.1 field trial control tomato late blight
3.1.1 test method
Test arrangement carries out in town Ying Shui village Zhang Qingxiang booth is jumped in the Tengchong County, Yunnan Province, it is serious that tomato late blight experimental field occurs over the years, tomato grows fine, the uniformities such as the soil types of each experimental plot, cultivation condition and water and fertilizer management, and test the last fortnight was not executed the bactericidal agent for preventing and treating disease.
Every community adopts 5 samplings, and whole blades of every strain are investigated in every some investigation 2-3 strain, with the number of the scab on every leaf, come classification to record total number of sheets, the sick number of sheets at different levels, calculate the blade incidence of disease, disease index, and contrast disease and refers to comparison, the calculating relative control effect.
Severity Scaling standard (take blade as unit)
0 grade: without scab;
1 grade: single blade has 3 of scabs;
3 grades: single blade has 4～6 of scabs;
5 grades: single blade has 7～10 of scabs;
7 grades: single blade has 11～20 of scabs, and part is intensive in flakes;
9 grades: single blade has the intensive leaf area that accounts for of scab more than 1/4th.
3.1.2 control time and number of times
Test is investigated 4 times altogether, radix investigation before medicine, after medicine 5 days for the first time, after medicine 5 days and after medicine, within 18 days, investigated for the third time for the second time.
3.1.3 drug effect computational methods
Sick leaf rate (%)=sick number of sheets/investigate total number of sheets * 100
Disease index=∑ (the sick numbers of sheets at different levels * relative level numerical value)/(investigating total number of sheets * 9) * 100
Control efficiency (%)=(disease index after disease index before 1-(blank district medicine * treatment region medicine)/(disease index before disease index after blank district medicine * treatment region medicine)) * 100
3.1.4 poisoning investigation method
After dispenser, whether continuous 7d range estimation medicament has poisoning to crop.
3.1.5 result of the test and analysis
Each processes the effect (table 2) of control tomato late blight
As can be seen from Table 2, pyraclostrobin and famoxadone are better than with composite its control efficiency of control tomato late blight of 1:2 ratio the preventive effect that pyraclostrobin and two kinds of single doses of famoxadone are processed with isoconcentration, there is good quick-acting, pyraclostrobin, Yu famoxadone has good lasting effect so that the 1:2 ratio is composite to tomato late blight, can be good at controlling the generation of late blight.According to the field range estimation, in the test dose scope, plant growth is normal, and the poisoning phenomenon to tomato does not all appear in each treatment agent, illustrates that it is safe to tomato.
3.2 field trial is prevented and treated downy mildew of garpe
3.2.1 test method
Test is at 4 points of Pingdu City wine-growing Di，Mei community, Shandong investigation, and every some investigation 2 strains, put down in writing occurring degree by staging, and grade scale is as follows:
0 grade: anosis;
1 grade: the sorus area accounts for below 5% of whole leaf area;
3 grades: the sorus area accounts for below the 6%-10% of whole leaf area;
5 grades: the sorus area accounts for below the 11%-20% of whole leaf area;
7 grades: the sorus area accounts for below the 21%-50% of whole leaf area;
9 grades: the sorus area accounts for more than 50% of whole leaf area.
4.1.2 control time and number of times
Test is investigated 4 times altogether, radix investigation before medicine, for the first time after medicine 14 days, after 14 days and medicine, within 21 days, investigated after medicine for the second time.
3.2.3 drug effect computational methods
Sick leaf rate (%)=sick number of sheets/investigate total number of sheets * 100
Disease index=∑ (the sick numbers of sheets at different levels * relative level numerical value)/(investigating total number of sheets * 9) * 100
Control efficiency (%)=(disease index after disease index before 1-(blank district medicine * treatment region medicine)/(disease index before disease index after blank district medicine * treatment region medicine)) * 100.
3.2.4 poisoning investigation method
After dispenser, whether continuous 14d range estimation medicament has poisoning to crop.
3.2.5 result of the test and analysis
Each processes the effect (table 3) of control cucumber downy mildew
Each processes the effect of control cucumber downy mildew table 3
The Mixed Pharmacy of different proportion, tested by different consumptions as can be seen from Table 3, and after medicine, its control to downy mildew of garpe all is better than contrasting medicament, and bactericidal effect increases progressively with the increase of dosage.According to the field range estimation, in the test dose scope, plant growth is normal, and the poisoning phenomenon to grape does not all appear in each treatment agent, illustrates that it is safe to grape.Advise that the bactericide different from the mechanism of action mixes use to delay the drug-fast generation of germ.
In sum, the present invention contains pyraclostrobin Yu the Bactericidal composite of famoxadone cucumber and downy mildew of garpe, tomato blight are had to good control efficiency, and it is to the target crop safety.Complex preparation has not only improved preventive effect, and has enlarged fungicidal spectrum, widens the scope of application, reduces costs, and multiple diseases is played to the double effect of controlling of a medicine, alleviates manpower and materials, improves productivity effect.So the invention of this complex preparation is of great significance social tool with popularization.
Claims (4)
1. a bactericidal composition that contains pyraclostrobin and famoxadone, it is characterized in that: the active ingredient of this bactericidal composition is that pyraclostrobin is Yu the famoxadone binary built, all the other are auxiliary element, and wherein the active ingredient pyraclostrobin is Yu the mass ratio of famoxadone is 1～50: 50～1.
2. bactericidal composition according to claim 1, it is characterized in that: pyraclostrobin is Yu the gross weight of famoxadone in preparation accounts for 1%～80% of the whole quality of the pharmaceutical preparations.
3. bactericidal composition according to claim 2, it is characterized in that: pyraclostrobin is Yu the gross weight of famoxadone in preparation accounts for 5%～60% of the whole quality of the pharmaceutical preparations.
4. according to claim 1 or 2 or 3 described bactericidal compositions, it is characterized in that: the formulation of this bactericidal composition is missible oil, suspending agent, wetting powder, water dispersible granules, aqueous emulsion, microemulsion, granule, microcapsule formulations
.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013103268328A CN103355334A (en) | 2013-07-31 | 2013-07-31 | Sterilization composition containing pyraclostrobin and famoxadone |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013103268328A CN103355334A (en) | 2013-07-31 | 2013-07-31 | Sterilization composition containing pyraclostrobin and famoxadone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103355334A true CN103355334A (en) | 2013-10-23 |
Family
ID=49358287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013103268328A Pending CN103355334A (en) | 2013-07-31 | 2013-07-31 | Sterilization composition containing pyraclostrobin and famoxadone |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103355334A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104488896A (en) * | 2014-12-18 | 2015-04-08 | 广西田园生化股份有限公司 | Compound composition containing methylsulfonylconazole and strobilurin fungicide and preparation |
| CN104663690A (en) * | 2015-02-16 | 2015-06-03 | 杭州宇龙化工有限公司 | Bactericidal composition containing pyraclostrobin and famoxadone |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101703053A (en) * | 2009-11-13 | 2010-05-12 | 陕西上格之路生物科学有限公司 | Germicide composite containing famoxadone |
| CN101755785A (en) * | 2009-12-21 | 2010-06-30 | 陈章艳 | Bactericide composition containing famoxadone |
-
2013
- 2013-07-31 CN CN2013103268328A patent/CN103355334A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101703053A (en) * | 2009-11-13 | 2010-05-12 | 陕西上格之路生物科学有限公司 | Germicide composite containing famoxadone |
| CN101755785A (en) * | 2009-12-21 | 2010-06-30 | 陈章艳 | Bactericide composition containing famoxadone |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104488896A (en) * | 2014-12-18 | 2015-04-08 | 广西田园生化股份有限公司 | Compound composition containing methylsulfonylconazole and strobilurin fungicide and preparation |
| CN104488896B (en) * | 2014-12-18 | 2016-08-24 | 广西田园生化股份有限公司 | Containing methylsulfonyl bacterium azoles and the complex composition of methoxy acrylic bactericide and preparation |
| CN104663690A (en) * | 2015-02-16 | 2015-06-03 | 杭州宇龙化工有限公司 | Bactericidal composition containing pyraclostrobin and famoxadone |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103271031A (en) | Sterilization composition containing cyanoacrylate bactericide and metalaxyl-M | |
| CN103355333A (en) | Sterilization composition containing pyraclostrobin and boscalid | |
| CN105409990A (en) | Sterilization composition containing pyraclostrobin and efficient metalaxyl-M | |
| CN103168780A (en) | Bactericidal composition containing fluopicolide and metrafenone | |
| CN103719102A (en) | Sterilization composite containing fluopyram and prothioconazole | |
| CN103355308A (en) | Sterilization composition containing prothioconazole and boscalid | |
| CN103081913A (en) | Sterilization composition containing boscalid and kresoxim-methyl | |
| CN105409976A (en) | Sterilization composition containing efficient metalaxyl-M and flumorph | |
| CN103141493A (en) | Bactericidal composition containing difenoconazole and benthiavalicarb-isopropyl | |
| CN103229767A (en) | Trifloxystrobin and bupirimate-containing sterilization composition | |
| CN103355334A (en) | Sterilization composition containing pyraclostrobin and famoxadone | |
| CN103355316A (en) | Bactericide composition containing N-methyl-3-(4-chloro)phenyl-5-methyl-5-pyridyl-3-methyl-oxazoline and methyl (E)-2-(2-((3-(4-chlorphenyl)-1-methyl-1H-pyrazolyl-5-oxy)methyl)phenyl-3-methoxyacrylate | |
| CN103688965A (en) | Bactericidal composition containing fluopyram and pyraclostrobin | |
| CN103931640A (en) | Bactericidal composition containing meptyldinocap and pyraclostrobin | |
| CN103688938A (en) | Bactericidal composition containing fluopyram and bupirimate | |
| CN103070174A (en) | Bactericidal composition containing fluopicolide and cyflufenamid | |
| CN103688951A (en) | Bactericidal composition containing fluopyram and pyrisoxazole | |
| CN103503879A (en) | Sterilization composition containing prothioconazole and bupirimate | |
| CN103355318A (en) | Sterilization composition containing pyrisoxazole and flumorph | |
| CN103355332A (en) | Sterilization composition containing SYP-Z048 and pyraclostrobin | |
| CN103503881A (en) | Sterilization composition containing prothioconazole and famoxadone | |
| CN103688939A (en) | Bactericidal composition containing fluopyram and ethirimol | |
| CN103141496A (en) | Sterilizing composite containing pyraclostrobin and penthiopyrad | |
| CN104126593A (en) | Sterilization composition containing ametoctradin and fluopyram | |
| CN103931624A (en) | Fungicidal composition containing prothioconazole and cyazofamid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20131023 |